ACS chemical neuroscience molecule spotlight on BMS-708163

Research output: Contribution to journalReview articlepeer-review

5 Scopus citations


BMS-708163 is a novel, sulfonamide containing γ-secretase inhibitor from Bristol-Myers Squibb Co. currently in Phase II clinical trials for the treatment of Alzheimer's disease (AD).

Original languageEnglish (US)
Pages (from-to)149-150
Number of pages2
JournalACS Chemical Neuroscience
Issue number3
StatePublished - Mar 21 2012
Externally publishedYes


  • Alzheimer's disease
  • GSI
  • amyloid hypothesis
  • gamma-secretase inhibitors

ASJC Scopus subject areas

  • Biochemistry
  • Physiology
  • Cognitive Neuroscience
  • Cell Biology

Fingerprint Dive into the research topics of 'ACS chemical neuroscience molecule spotlight on BMS-708163'. Together they form a unique fingerprint.

Cite this